Use of neutrophil inhibitors in the manufacture of medicaments for treating inflammation and pathological conditions
Номер патента: NZ505450A
Опубликовано: 01-02-2002
Автор(ы): David Lee Foster, George Phillip Vlasuk, Matthew Moyle
Принадлежит: Corvas Int Inc
Опубликовано: 01-02-2002
Автор(ы): David Lee Foster, George Phillip Vlasuk, Matthew Moyle
Принадлежит: Corvas Int Inc
Реферат: An isolated DNA sequence and a mature Neutrophil Inhibitor Factor (NIF1FL) amino acid sequence useful for treating a pathological condition in a mammal that is ameliorated by inhibition of neutrophil activity. It is also useful for preventing or decreasing inflammatory responses in mammals. Neutrophil Inhibitor Factor may be obtained from parasitic worms.
Methods and agents for treating soft tissue inflammation and associated diseases and conditions
Номер патента: WO2024158300A1. Автор: Sandi Dempsey,Barnaby May,Robert Veale. Владелец: Aroa Biosurgery Limited. Дата публикации: 2024-08-02.